POST-USTEKINUMAB INDUCTION IL-12, IL-23, AND USTEKINUMAB LEVELS ARE ASSOCIATED WITH CLINICAL RESPONSE IN A MULTICENTRE PROSPECTIVE COHORT STUDY OF CROHN'S DISEASE PATIENTS: RESULTS FROM THE AURORA STUDY

被引：0
|
作者：
An, Yoon-Kyo
Lindsay, Niamh
Allan, Natalie
Khoo, Emi
Fernandes, Richard
Amiss, Anna
Hai Pham
Wong, Kam Fai
Ooi, Soong-Yuan
Thin, Lena
Lightowler, Daniel
Connor, Susan J.
Williams, Astrid-Jane
De Cruz, Peter
Suen, Christopher Li Wai
Kariyawasam, Viraj C.
Mitrev, Nikola
Ghaly, Simon
Andrews, Jane M.
Christensen, Britt
Sparrow, Miles
White, Lauren S.
Bryant, Robert V.
Ding, Nik S.
Leong, Rupert
Van Langenberg, Daniel R.
Seltenreich, Hansjoerg
Subramaniam, Kavitha
Radford-Smith, Graham L.
Begun, Jakob
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1749
引用
收藏
页码：S1108 / S1108
页数：1
相关论文
共 50 条
  • [1] Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort
    An, Y. K.
    Lindsay, N.
    Allan, N.
    Khoo, E.
    Fernandes, R.
    Amiss, A.
    Pham, H.
    Wong, K. F.
    Ooi, S. Y.
    Thin, L.
    Lightowler, D.
    Connor, S. J.
    Williams, A. J.
    De Cruz, P.
    Suen, C. Li Wai
    Kariyawasam, V.
    Mitrev, N.
    Ghaly, S.
    Andrews, J. M.
    Christensen, B.
    Sparrow, M. P.
    White, L. S.
    Bryant, R. V.
    Ding, N.
    Leong, R.
    Van Langenberg, D.
    Seltenreich, H.
    Subramaniam, K.
    Radford-Smith, G.
    Begun, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 793 - 794
  • [2] Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort
    An, Y-K
    Lindsay, N.
    Allan, N.
    Khoo, E.
    Amiss, A.
    Moniruzzaman, M.
    Fernandes, R.
    Ooi, S-Y
    Thin, L.
    Lightowler, D.
    Connor, S.
    Williams, A-J
    De Cruz, P.
    Suen, C. Li Wai
    Kariyawasam, V.
    Mitrev, N.
    Ghaly, S.
    Andrews, J. M.
    Christensen, B.
    Sparrow, M.
    White, L.
    Bryant, R. V.
    Ding, N.
    Leong, R.
    Van Langenberg, D.
    Seltenreich, H.
    Subramaniam, K.
    Radford-Smith, G.
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 146 - 147
  • [3] BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY
    Bertani, L.
    D'Antongiovanni, V
    Coppini, F.
    Benvenuti, L.
    Bronzini, F.
    Ceccarelli, L.
    Fornai, M.
    De Bortoli, N.
    Bellini, M.
    Antonioli, L.
    Costa, F.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S73 - S73
  • [4] The anti-IL-23/IL-12 agent Ustekinumab is an effective and safe induction therapy in patients with Crohn's disease refractory or intolerant to anti-TNF: a multicentre Italian study
    Gubbiotti, A.
    Barberio, B.
    Zingone, F.
    D'Inca, R.
    Bertani, L.
    Ferronato, A.
    Urbano, M. T.
    Sablich, R.
    Savarino, E. V.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S379 - S379
  • [5] BASELINE CYTOKINE LEVELS AND MICROBIOME SIGNATURES ARE ASSOCITED WITH CLINICAL RESPONSE FOLLOWING USTEKINUMAB INDUCTION IN A MULTI-CENTRE PROSPECTIVE COHORT STUDY OF CROHN'S DISEASE PATIENTS: RESULTS FROM THE AURORA STUDY
    An, Yoon-Kyo
    Lindsay, Niamh
    Allan, Natalie
    Khoo, Emi
    Fernandes, Richard
    Amiss, Anna
    Pham, Hai
    Giri, Rabina
    Ooi, Soong-Yuan
    Thin, Lena
    Lightowler, Daniel
    Connor, Susan J.
    Williams, Astrid-Jane
    De Cruz, Peter
    Suen, Christopher Li Wai
    Kariyawasam, Viraj C.
    Mitrev, Nikola
    Ghaly, Simon
    Andrews, Jane M.
    Christensen, Britt
    Sparrow, Miles
    White, Lauren S.
    Bryant, Robert V.
    Ding, Nik S.
    Leong, Rupert
    Van Langenberg, Daniel R.
    Seltenreich, Hansjoerg
    Subramaniam, Kavitha
    Radford-Smith, Graham L.
    Begun, Jakob
    GASTROENTEROLOGY, 2023, 164 (06) : S657 - S658
  • [6] Blockade of the IL-12/IL-23 pathway with ustekinumab modulates the composition of the microbiome in lesional skin from psoriasis patients
    Tsianakas, A.
    Baumann, C.
    Riepe, C.
    Magnolo, N.
    Dobrindt, U.
    Luger, T.
    Loser, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S68 - S68
  • [7] Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
    van Vollenhoven, Ronald F.
    Hahn, Bevra H.
    Tsokos, George C.
    Wagner, Carrie L.
    Lipsky, Peter
    Touma, Zahi
    Werth, Victoria P.
    Gordon, Robert M.
    Zhou, Bei
    Hsu, Benjamin
    Chewier, Marc
    Triebel, Manon
    Jordan, Jarrat L.
    Rose, Shawn
    LANCET, 2018, 392 (10155): : 1330 - 1339
  • [8] Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
    Biemans, Vince B. C.
    van der Meulen-de Jong, Andrea E.
    van der Woude, Christine J.
    Lowenberg, Mark
    Dijkstra, Gerard
    Oldenburg, Bas
    de Boer, Nanne K. H.
    van der Marel, Sander
    Bodelier, Alexander G. L.
    Jansen, Jeroen M.
    Haans, Jeoffrey J. L.
    Theeuwen, Rosaline
    de Jong, Dirk
    Pierik, Marie J.
    Hoentjen, Frank
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (01): : 33 - 45
  • [9] Relationship of C-reactive protein with clinical response following therapy with monoclonal antibody to IL-12/23p40 (Ustekinumab) in Crohn's disease
    de Villiers, Willem J.
    Toedter, Gary
    Lang, Yinghua
    Blank, Marion
    Sandborn, William J.
    GASTROENTEROLOGY, 2008, 134 (04) : A491 - A491
  • [10] Ustekinumab Is Effective for the Induction and Maintenance of Response in Crohn's Disease: A Multi-center Cohort Study
    Ma, Christopher
    Fedorak, Richard
    Kaplan, Gilaad
    Dieleman, Levinus
    Kroeker, Karen
    Seow, Cynthia
    Leung, Yvette
    Novak, Kerri
    Halloran, Brendan
    Huang, Vivian
    Wong, Karen
    Devlin, Shane
    Ghosh, Subrata
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S294 - S294
12345